Abstract:Background The objective of this study was to update the association between multivitamin supplementation and total or cause-specific mortality in a population with a high prevalence of undernutrition in China. Methods The Linxian Dysplasia Nutrition Intervention Trial was a randomized, double-blind, placebo-controlled trial in which 3318 persons aged 40-69 years with esophageal squamous dysplasia were assigned to receive daily multivitamin supplementation or a placebo for 6 years and were followed for 29 years. The primary outcome was esophageal/gastric cardia cancer mortality. The data were analyzed with Cox proportional hazards regression models. Subgroup analyses were performed by common characteristics such as age and gender. Results The cumulative total mortality was 83.5%. Multivitamin supplementation did not affect total or cause-specific mortality in the participants as a whole (hazard ratio [HR], 0.96; 95% confidence interval [CI], 0.89-1.03). Subgroup analyses showed that no association between multivitamin supplementation and all-cause mortality was observed in men (HR, 0.90; 95% CI, 0.81-1.01), women (HR, 1.01; 95% CI, 0.91-1.12), younger participants (HR, 0.97; 95% CI, 0.87-1.08), or older participants (HR, 0.94; 95% CI, 0.85-1.04). Significant reductions in heart disease mortality (HR, 0.64; 95% CI, 0.47-0.87) and cerebrovascular disease mortality (HR, 0.74; 95% CI, 0.56-1.00) were seen in older men. In a subgroup of younger men and a subgroup of moderate or severe dysplasia, subjects receiving multivitamin supplementation had a lower risk of esophageal/cardia cancer mortality (HR for younger men, 0.76; 95% CI, 0.58-0.99; HR for moderate or severe dysplasia, 0.76; 95% CI, 0.58-1.00). No association between multivitamin supplementation and any cause-specific mortality was observed in a mild dysplasia population. Conclusions Multivitamin supplementation in a population with esophageal squamous dysplasia was not associated with the risk of total mortality in the 35-year follow-up of this randomized controlled trial. In light of this and previous trials, multivitamin supplements should be used thoughtfully to improve health status of populations with esophageal squamous dysplasia. Lay summary Multivitamin supplementation is common, yet its effect on mortality is unclear. The aim of this study was to update the long-term effects of multivitamin supplementation on total and cause-specific mortality during nearly 35 years of follow-up in the Linxian Dysplasia Nutrition Intervention Trial in China. Multivitamin supplementation in a population with esophageal squamous dysplasia was not associated with the risk of total mortality in the 35-year follow-up of this randomized controlled trial, and this indicates that multivitamin supplements should be used thoughtfully to improve health status.

Body mass index and risk of upper gastrointestinal cancer: A 30-year follow-up of the Linxian dysplasia nutrition intervention trial cohort.

Body mass index and risk of gastric cancer: A 30-year follow-up study in the Linxian general population trial cohort.

Association Between Tooth Loss and Upper Gastrointestinal Cancer: A 30‐year Follow‐up of the Linxian Dysplasia Nutrition Intervention Trial Cohort

Oral Leukoplakia and the Long‐term Risk of Upper Gastrointestinal Cancer Deaths in the Linxian Dysplasia Population

Fresh Fruit Consumption May Decrease the Long‐term Risk of Esophageal Cancer Mortality: A 30‐year Follow‐up Study in the Linxian Dysplasia Nutrition Intervention Trial (NIT)

Association between oral leukoplakia and risk of upper gastrointestinal cancer death: A follow-up study of the Linxian General Population Trial.

Dietary Components and Risk of Total, Cancer and Cardiovascular Disease Mortality in the Linxian Nutrition Intervention Trials Cohort in China

Family History and Risk of Upper Gastrointestinal Cancer in the Linxian General Population

Body mass index and esophageal and gastric cancer: A pooled analysis of 10 population-based cohort studies in Japan.

Short-term and long-term effect of nutrition intervention in the Linxian Dysplasia Nutrition Intervention Trial and the reason for disappearance of the intervention effect: A cohort study

Mortality after multivitamin supplementation: Nearly 35-year follow-up of the randomized Linxian Dysplasia Nutrition Intervention Trial

Combined risk factors and risk of upper gastrointestinal cancer mortality in the Linxian general population

The Randomized Linxian Dysplasia Nutrition Intervention Trial after 26 Years of Follow-Up: No Effect of Multivitamin Supplementation on Mortality

Body Mass Index and the Risk of Gastric Cancer in Males: a Prospective Cohort Study

Changes of Body Mass Index and Body Shape in Relation to Risk of Gastric Cancer: A Population-Based Case-Control Study

Association of Body Mass Index and the Risk of Gastro-Esophageal Cancer: A Mendelian Randomization Study in a Japanese Population

Association between type of drinking water and upper gastrointestinal cancer incidence in the Linxian General Population

Adiposity and risks of colorectal and small intestine cancer in Chinese adults: a prospective study of 0.5 million people

Adult Height, Body Mass Index Change, and Body Shape Change in Relation to Esophageal Squamous Cell Carcinoma Risk: A Population‐based Case‐control Study in China

Colorectal cancer in the Linxian China Nutrition Intervention Trial: Risk factors and intervention results

Serum Levels of Androgens, Estrogens, and Sex Hormone Binding Globulin and Risk of Primary Gastric Cancer in Chinese Men: A Nested Case-Control Study.